New research suggest that the nucleus basalis of Meynert white matter pathways could serve as non-invasive biomarkers indicating risk for clinical conversion & cortical pathology in iRBD & #Parkinsons, both baseline & longitudinal cognitive function
academic.oup.com/braincomms/a...

Central cholinergic white matter pathways in prodromal and early manifest Lewy body disease https://www.medrxiv.org/content/10.1101/2025.03.06.25323482v1

Central cholinergic degeneration in prodromal and early manifest Parkinsons disease: relation to cognition, clinical phenotype, and future conversion https://www.medrxiv.org/content/10.1101/2024.12.31.24319810v1